Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lung cancer: current therapies and new targeted treatments.

Lancet (London, England) - 21 Jan 2017

Hirsch Fred R, Scagliotti Giorgio V, Mulshine James L, Kwon Regina, Curran Walter J, Wu Yi-Long, Paz-Ares Luis

Abstract excerpt

Lung cancer is the most frequent cause of cancer-related deaths worldwide. Every year, 1·8 million people are diagnosed with lung cancer, and 1·6 million people die as a result of the disease. 5-year survival rates vary from 4-17% depending on stage and regional differences. In this Seminar, we discuss existing treatment for patients with lung cancer and the promise of precision medicine, with special emphasis on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Combined Modality Therapy

Share to Early Detection of Cancer

Share to Immunotherapy

Share to Lung Neoplasms

Share to Mutation

Share to Survival Rate

Source

Identifiers

PMID: 27574741
DOI: 10.1016/S0140-6736(16)30958-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lung cancer: current therapies and new targeted treatments.PMID 27574741Read ↗

Lung cancer: Biology and treatment options.Semantic proximity Read ↗

Recent advances in the management of non-small cell lung cancerSemantic proximity Read ↗

Personalized Therapy of Non-small Cell Lung Cancer (NSCLC).Semantic proximity Read ↗

Lung cancer: not just for smokers. People who never smoked may have a different form of the disease that responds better to a new generation of targeted medications.Semantic proximity Read ↗

Targeted therapy moves to earlier stages of non-small-cell lung cancer: emerging evidence, controversies and future challenges.Semantic proximity Read ↗

Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments.Semantic proximity Read ↗

Prevention of lung cancer. The new millennium.Semantic proximity Read ↗

[The Cutting-edge of Medicine; Clinico-pathogenetic background and approach for early detection of lung cancer].Semantic proximity Read ↗

Personalized treatment of lung cancer.Semantic proximity Read ↗

Lung Cancer: Are we up to the Challenge?Semantic proximity Read ↗

Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer.Semantic proximity Read ↗

Advances in Targeted Therapy Against Driver Mutations and Epigenetic Alterations in Non-Small Cell Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.